Section 112(a) Enablement and Written Description: Leveraging CCPA and Early Federal Circuit Decisions

Capitalizing on Precedent to Withstand 112(a) Rejections and Attacks on Patent Validity and Patentability

A live 90-minute CLE webinar with interactive Q&A


Thursday, August 24, 2017 (in 3 days)
1:00pm-2:30pm EDT, 10:00am-11:30am PDT


This CLE webinar will provide guidance to patent counsel on leveraging decisions by the Court of Customs and Patent Appeals (CCPA) and the Federal Circuit regarding application of §112 written description. The panel will examine lessons learned through CCPA and early Federal Circuit decisions and offer strategies to overcome the challenges of §112.

Description

Federal Circuit patent decisions, such as Adrian Rivera v. ITC, as well as important decisions such as Rochester and Ariad, demonstrate that §112(a) (para. 1 pre-AIA) issues remain a constant challenge for practitioners.

The CCPA developed a rich body of §112 jurisprudence, which the Federal Circuit adopted as binding precedent, providing a treasure trove of arguments for practitioners prosecuting, defending before PTAB in AIA post-grant proceedings, and litigating patents in the face of assertions of lack of written description support and lack of enablement.

Counsel can draw on CCPA cases and early Federal Circuit cases for guidance in presenting evidence and arguments of written description support and enablement.

Listen as our authoritative panel of U.S. patent attorneys examines the lessons from select CCPA and early Federal Circuit decisions (still cited in the Manual of Patent Examining Procedure, MPEP), as well as by the recent §112 Federal Circuit decisions, to avoid repeating past mistakes and to truly promote the progress of the useful arts and sciences as mandated by the Constitution.

Outline

  1. Lessons from the CCPA and early Federal Circuit decisions that reversed §112 rejections/invalidity holdings
    1. In re Schechter, 205 F.2d 185, 98 USPQ 144 (CCPA 1953) (claim rejected as improper Markush; reversed)
    2. In re Robins, 429 F.2d 452, 166 USPQ 552 (CCPA 1970) (examples not required)
    3. In re Borkowski, 422 F.2d 904, 164 USPQ 642 (CCPA 1970) (“magical relation between the number of representative examples and the breadth of the claims”)
    4. In re Brower, 433 F.2d 813, 167 USPQ 684 (CCPA 1970) (patent application found enabled for priority date benefit)
    5. In re Oda, 443 F.2d 1200, 170 USPQ 268 (CCPA 1971) (correcting obvious error not new matter)
    6. In re Marzocchi, 439 F.2d 220, 169 USPQ 367 (CCPA 1971) (“first paragraph of § 112 requires nothing more than objective enablement. How such a teaching is set forth, either by the use of illustrative examples or by broad terminology, is of no importance.”)
    7. In re Moore, 439 F.2d 1232, 169 USPQ 236 (CCPA 1971) [analyze 112(b) first (rejection at issue is one for indefiniteness)]
    8. In re Gardner, 475 F.2d 1389, 177 USPQ 396 (CCPA 1973) (meeting “how-to-use” requirement)
    9. In re Smythe, 480 F.2d 1376, 178 USPQ 279 (CCPA 1973) (liquids and gases other than air)
    10. In re Angstadt, 537 F.2d 498, 190 USPQ 214 (CCPA 1976) (not required to test every species covered by a claim)
    11. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976) (range)
    12. In re Johnson, 558 F.2d 1008, 194 USPQ 187 (CCPA 1977) (proviso)
    13. In re Hogan, 559 F.2d 595, 194 USPQ 527 (CCPA 1977) (date benefit)
    14. In re Harnisch, 631 F.2d 716, 206 USPQ 300 (CCPA 1980) (improper Markush groups)
    15. In re Breslow, 616 F.2d 516, 205 USPQ 221 (CCPA 1980) (enabled)
    16. In re Rasmussen, 650 F.2d 1212, 211 USPQ 323 (CCPA 1981) (claim may be broader than the specific embodiment disclosed in a specification)
    17. In re Bundy, 642 F.2d 430, 209 USPQ 48 (CCPA 1981) (how-to-use requirement of the first paragraph of §112 has been adequately complied with)
    18. In re Marosi, 710 F.2d 799, 218 USPQ 289 (CCPA 1983) (sufficiently enabled; “appellants’ invention does not reside in such a number”)
    19. L. Gore & Associates Inc. v. Garlock Inc., 721 F.2d 1540 (Fed. Cir 1983) (“no evidence and no finding that those skilled in the art would have found the specification non-enabling”)
    20. Atlas Powder Co. v. E.I. duPont de Nemours & Co., 750 F.2d 1569, 224 USPQ 409 (Fed. Cir. 1984) (“Even if some of the claimed combinations were inoperative, the claims are not necessarily invalid”)
    21. Cross v. Iizuka, 753 F.2d 1040 (Fed. Cir. 1985) (“how-to-use” requirement met)
    22. Spectra-Physics Inc. v. Coherent Inc., 3 USPQ2d 1737 (Fed. Cir. 1987), cert. denied, 484 U.S. 954 (1987) (enabled but failed to disclose best mode)
    23. In re Wands, 858 F.2d 731, 8 USPQ2d 1400 (Fed. Cir. 1988) (some experimentation okay)
    24. Vas-Cath Inc. v. Mahurkar, 935 F.2d 1555, 19 USPQ2d 1111 (Fed. Cir. 1991)
    25. In re Brana, 51 F.2d 1560, 34 USPQ2d 1437 (Fed. Cir. 1995) (PTO has the initial burden of challenging a presumptively correct assertion of utility in the disclosure)
  2. Recent §112 Federal Circuit decisions
    1. Univ. of Rochester
    2. Ariad

Benefits

Our panel will review these and other important issues:

  • What lessons can patent counsel draw from CCPA decisions when making arguments of written description support and enablement?
  • What steps can counsel for patentees take to meet the written description and enablement requirements and withstand invalidity/unpatentability challenges based on written description and enablement?
  • What steps should patent counsel take going forward to avoid repeating mistakes of the past?

Faculty

Thomas L. Irving, Partner
Finnegan Henderson Farabow Garrett & Dunner, Washington, D.C.

Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.

Donna M. Meuth, Associate General Counsel
Eisai, Andover, Mass.

Ms. Meuth has diverse experience in intellectual property law, including patent portfolio management, patent prosecution and litigation. Her technical focus is in the pharmaceutical, chemical and biotechnology arts. She has significant interference experience and litigation experience, in particular ANDA litigation for branded pharmaceuticals.

Amanda K. Murphy, Ph.D.
Finnegan Henderson Farabow Garrett & Dunner, Washington, D.C.

Dr. Murphy focuses her practice on client counseling and patent prosecution for a range of clients. She prepares new patent applications, prosecutes U.S. and foreign applications, and represents applicants at appeals and oral hearings before the PTAB. She has experience in prosecuting inter partes and ex partes reexamination applications, reissue applications, and patent term extension applications for approved pharmaceuticals, including obtaining supplemental protection certificates in Europe.


Live Webinar

Live Webinar $297.00

Add a colleague on the same connection in the same room for only $97.00 in the shopping cart or by calling customer service.

This webinar is eligible for at least 1.5 general CLE credits.

CLE credits are not available for PR.

*In KS, OH, PA, for more than 1 attendee on the connection you must contact Strafford CLE via email or call 1-800-926-7926 ext. 35 prior to the program for special instructions.


Recordings

CLE On-Demand - Streaming Video

Includes recorded streaming video of full program plus PDF handouts.

On-demand is the only recorded format recognized for CLE credits in DE, IN, KS, LA, MS, NC, OH, OK, SC, TN, VA, WI.

AK, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN*, KS, KY, LA, ME, MN, MO, MT, NC, ND, NH**, NJ, NM, NV, NY, OH*, OK, OR, PA, SC, TN, TX, UT, VA, VT, WA, WI, WV, WY (Note: Some states restrict CLE eligibility based on the age of a program. Refer to our state CLE Map for additional information.)

*Only available for attorneys admitted for more than two years. For OH CLE credits, only programs recorded within the current calendar year are eligible - contact the CLE department for verification.

**NH attendees must self-determine if a program is eligible for credit and self-report their attendance.

CLE On-Demand Video $297.00
Available 48 hours after the live event

How does this work?


Recorded Event

Includes full event recording plus handouts (available after live webinar).

Strafford is an approved provider and self-study CLE credit is available in most states.

AK, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, KY, ME, MN, MO, MT, ND, NJ, NM, NY, OR, PA, TN, TX, UT, VT, WA, WV, WY (Note: Some states restrict CLE eligibility based on the age of a program. Refer to our state CLE Map for additional information.)

Strafford will process CLE credit for one person on each recording.

Additional copies of a recording can be purchased at a discount. Please call Strafford Customer Service toll-free at 1-800-926-7926 ext 10 or email customerservice@straffordpub.com to place your order.

Recorded Webinar Download $297.00
Available 48 hours after the live event

How does this work?

Recorded Audio Download (MP3) $297.00
Available 24 hours after the live event

How does this work?

DVD (Slide Presentation with Audio) $297.00 plus $9.45 S&H
Available ten business days after the live event

How does this work?


Registration Plus Recorded Event

Best value!

Live Webinar & Webinar Download $394.00

Recorded Webinar Download Only $97.00 with Registration/Webinar Combo

Live Webinar & Audio Download $394.00

Recorded Audio Download (MP3) Only $97.00 with Registration/MP3 Combo

Live Webinar & DVD $394.00 plus $9.45 S&H

DVD (Slide Presentation with Audio) Only $97.00 with Registration/DVD Combo


Webinar

Strafford webinars offer several options for participation: online viewing of speaker-controlled PowerPoint presentations with audio via computer speakers or via phone; or audio only via telephone (download speaker handouts prior to the program).  Please note that our webinars do not feature videos of the presenters.

Program Materials

Requires Adobe Reader 8 or later. Download Acrobat FREE.

Program Materials

Requires Adobe Reader 8 or later. Download Acrobat FREE.

or call 1-800-926-7926

Can't Attend the Live Program?

CLE Credits By State

See CLE State Map >

or call 1-800-926-7926

Customer Reviews

I liked the practical insights, particularly when tied to cases the presenters had worked on.

Michael Gray

Kohler

Strafford provided an enthusiastic presentation that focused on patent practice, not theory.

David H. Vance

Vance Intellectual Property

I liked the topic and the tools provided in the handouts.

Mildred Johnson

Texas Tech University Health Sciences Center

The program was practical and showed both sides of the issue.

Kristina Pasko

Lowenstein Sandler

I thought Strafford's program provided good information without being too lengthy.

Erin Aures

McCarter & English

or call 1-800-926-7926

Patent Law Advisory Board

Charles S. Baker

Partner

Locke Lord

David S. Bloch

Partner

Winston & Strawn

Irah H. Donner

Partner

Manatt

Ian N. Feinberg

Partner

Feinberg Day Alberti & Thompson

Anthony J. Fitzpatrick

Partner

Duane Morris

David Segal

Senior IP Counsel

Intel

Astrid R. Spain

Partner

Jones Day

Mark P. Wine

Partner

Orrick

or call 1-800-926-7926

Our Guarantee

Strafford webinars are backed by our 100% Unconditional Money-Back Guarantee: if you are not satisfied with any of our products, simply let us know and get a full refund. For more information regarding complaints and refunds, please contact us at 1-800-926-7926 ext 10. Complaints regarding this program can be submitted via the course evaluation found in the “Thank you” e-mail at the end of the course.